Acorda Therapeutics, Inc. (NASDAQ: ACOR) was a big mover last session, as the company saw its shares rise by roughly 8% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company as the stock is now almost 12% in the past one-month time frame.
This biotechnology company has seen no estimate revision over the past 30 days while its Zacks Consensus Estimate has moved down over the same time frame, suggesting there may be trouble down the road. So make sure to keep an eye on this stock going forward to see if this recent move higher can last.
Acorda Therapeutics has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Some better-ranked stocks in the same industry include ANI Pharmaceuticals, Inc. (NASDAQ: ANIP), Gilead Sciences Inc. (NASDAQ: GILD) and Illumina Inc. (NASDAQ: ILMN). All these stocks carry a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
This biotechnology company has seen no estimate revision over the past 30 days while its Zacks Consensus Estimate has moved down over the same time frame, suggesting there may be trouble down the road. So make sure to keep an eye on this stock going forward to see if this recent move higher can last.
Acorda Therapeutics has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Some better-ranked stocks in the same industry include ANI Pharmaceuticals, Inc. (NASDAQ: ANIP), Gilead Sciences Inc. (NASDAQ: GILD) and Illumina Inc. (NASDAQ: ILMN). All these stocks carry a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
ACORDA THERAPT (NASDAQ: ACOR): Free Stock Analysis Report
ANI PHARMACEUT (NASDAQ: ANIP): Free Stock Analysis Report
ILLUMINA INC (NASDAQ: ILMN): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research